NET PROFIT (x1000 EUR)
EMPLOYEES
Fisher Scientific Biotech Line A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 0 | 0 | 0 |
Earnings before taxes | 1,373 | 16,829 | -923 |
Total assets | 1,662,397 | 1,063,813 | 1,078,562 |
Current assets | 5,147 | 4,699 | 19,444 |
Current liabilities | 10,311 | 9,366 | 69,344 |
Equity capital | 1,652,086 | 1,054,447 | 1,009,217 |
- share capital | 67 | 68 | 68 |
Employees (average) | 15 | 15 | 15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 99.4% | 99.1% | 93.6% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio | 49.9% | 50.2% | 28.0% |
Return on equity (ROE) | 0.1% | 1.6% | -0.1% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.